All Stories

  1. Active Surveillance for Low-risk Prostate Cancer: Are All Criteria Similar?
  2. Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy
  3. PD10-03 EXTERNAL VALIDATION OF THE NEUROGENIC BLADDER SYMPTOM SCORE IN MULTIPLE SCLEROSIS PATIENTS WITH LOWER URINARY TRACT DYSFUNCTION
  4. MP26-16 NEUTROPHIL TO LYMPHOCYTE RATIO, A NEW PROGNOSTIC FACTOR IN NON MUSCLE INVASIVE BLADDER CANCER
  5. MP71-12 INCREASE OF FRAMINGHAM RISK IS ASSOCIATED WITH SEVERITY OF LOWER URINARY TRACT SYMPTOMS: CONFIRMING RELATIONSHIP BETWEEN BOTH DISEASES
  6. MP71-08 METABOLIC PROFILE CAN BE A LEADING PATHOGENETIC FACTOR FOR BENIGN PROSTATIC ENLARGEMENT
  7. Increase of Framingham cardiovascular disease risk score is associated with severity of lower urinary tract symptoms
  8. How to define cumulative cancer length for selecting candidate for active surveillance?
  9. Different levels of Cd45pos leukocytes in the semen of patients with low testicular volume
  10. Prevalence of Intratubular Germ Cell Neoplasia and Multifocality in Testicular Germ Cell Tumors ≤ 2 cm: Relationship With Other Pathological Features
  11. Relationship between urodynamic findings and sexual function in multiple sclerosis patients with lower urinary tract dysfunction
  12. Determinants of Sexual Impairment in Multiple Sclerosis in Male and Female Patients with Lower Urinary Tract Dysfunction: Results from an Italian Cross‐Sectional Study
  13. Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study
  14. Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial)
  15. Insulin Resistance Is an Independent Predictor of Severe Lower Urinary Tract Symptoms and of Erectile Dysfunction: Results from a Cross‐Sectional Study
  16. Prostatic Artery Embolization for Prostate Volume Greater Than 80 cm3: Results From a Single-center Prospective Study
  17. Functional characterization of platelets in patients with arterial erectile dysfunction
  18. 5ARIs and PSA: Evidences
  19. Tailored treatment including radical prostatectomy and radiation therapy + androgen deprivation therapy versus exclusive radical prostatectomy in high-risk prostate cancer patients: results from a prospective study
  20. Correlation Between Lipid Profile and Heme Oxygenase System in Patients With Benign Prostatic Hyperplasia
  21. PD25-09 NON ALCOHOLIC FATTY LIVER DISEASE IS AN INDEPENDENT PREDICTOR OF MODERATE-SEVERE LOWER URINARY TRACT SYMPTOMS IN METABOLIC SYNDROME PATIENTS: RESULTS FROM A CROSS-SECTIONAL STUDY
  22. PD14-02 PERCENTAGE OF CANCER INVOLVEMENT IN POSITIVE CORES CAN PREDICT UNFAVOURABLE DISEASE IN MEN WITH LOW-RISK PROSTATE CANCER BUT ELIGIBLE FOR THE PROSTATE CANCER INTERNATIONAL: ACTIVE SURVEILLANCE CRITERIA
  23. PD25-06 INSULIN RESISTANCE IS SIGNIFICANTLY ASSOCIATED WITH SEVERITY OF LOWER URINARY TRACT SYMPTOMS AND WITH ERECTILE DYSFUNCTION: RESULTS FROM A CROSS-SECTIONAL STUDY
  24. MP19-05 HEME OXYGENASE-1 PROSTATIC LEVELS ARE SIGNIFICANTLY LOWER IN PATIENTS AFFECTED BY MODERATE-SEVERE LUTS SECONDARY TO BENIGN PROSTATIC HYPERPLASIA: A PILOT STUDY
  25. PD5-07 INTRATUBULAR GERM CELL NEOPLASIA AND MULTIFOCALITY IN TESTICULAR GERM CELL TUMORS
  26. MP10-07 MULTIFOCALITY IN TESTICULAR GERM CELL TUMOR (TGCT): WHAT IS THE SIGNIFICANCE OF THIS FINDING?
  27. MP80-07 DEPRESSION AND HIGH EXPANDENDED DISABILITY STATUS SCALE (EDSS) ARE INDEPENDENT PREDICTORS OF SEXUAL DYSFUNCTION IN MULTIPLE SCLEROSIS PATIENTS: ANALYSIS FROM A CROSS-SECTIONAL STUDY
  28. Percentage of cancer involvement in positive cores can predict unfavorable disease in men with low-risk prostate cancer but eligible for the prostate cancer international: Active surveillance criteria
  29. PD23-07 SERENOA REPENS, LYCOPENE AND SELENIUM VS. TAMSULOSIN IN THE TREATMENT OF LUTS / BPH: AN ITALIAN MULTICENTER RANDOMIZED COMPARATIVE STUDY BETWEEN SINGLE OR COMBINATION THERAPIES. (PROCOMB STUDY)
  30. AlgaEcklonia bicyclis,Tribulus terrestris, and Glucosamine Oligosaccharide Improve Erectile Function, Sexual Quality of Life, and Ejaculation Function in Patients with Moderate Mild-Moderate Erectile Dysfunction: A Prospective, Randomized, Placebo-Cont...
  31. Male Accessory Gland Infection: Relevance of Serum Total Testosterone Levels
  32. Inhibitors of apoptosis proteins in experimental benign prostatic hyperplasia: effects of serenoa repens, selenium and lycopene
  33. Pneumatic Lithotripsy versus Holmium:YAG Laser Lithotripsy for the Treatment of Single Ureteral Stones: A Prospective, Single-Blinded Study
  34. Multifocality in testicular germ cell tumor (TGCT): what is the significance of this finding?
  35. Risk factors of sexual dysfunction after transurethral resection of the prostate (TURP): A12 months follow-up
  36. Genito-Urological Cancers in Elderly Patients
  37. Combination of intralesional verapamil and oral antioxidants for Peyronie's disease: a prospective, randomised controlled study
  38. Potential Efficacy of Some African Plants in Benign Prostatic Hyperplasia and Prostate Cancer
  39. 1234 PREDICTIVE FACTORS OF ERECTILE DYSFUNCTION AFTER TURP IN POTENT PATIENTS
  40. Effects of Serenoa Repens, Selenium and Lycopene (Profluss®) on chronic inflammation associated with Benign Prostatic Hyperplasia: results of “FLOG” (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study
  41. Unusual Presentation of Tuberous Sclerosis Complex
  42. Polyphenols: Key Issues Involved in Chemoprevention of Prostate Cancer
  43. Dietary patterns and prostatic diseases
  44. 1978 EFFECTS OF SERENOA REPENS, SELENIUM AND LYCOPENE ON CHRONIC INFLAMMATION ASSOCIATED WITH BPH: RESULTS OF A MULTICENTRE ITALIAN STUDY “FLOG” (FLOGOSIS AND PROFLUSS IN PROSTATIC AND GENITAL DISEASE)